|
Canada-0-CLAMPS Azienda Directories
|
Azienda News:
- Advances in Cancer Research | Book series - ScienceDirect
Read the latest chapters of Advances in Cancer Research at ScienceDirect com, Elsevier’s leading platform of peer-reviewed scholarly literature
- Advances in Cancer Research | All Bookseries Volumes | ScienceDirect . . .
Read the latest chapters of Advances in Cancer Research at ScienceDirect com, Elsevier’s leading platform of peer-reviewed scholarly literature
- Patient-derived xenograft models: Current status, challenges, and . . .
Despite advancing therapeutic treatments, cancer remains the leading cause of death worldwide, with most of its patients developing drug resistance and recurrence after initial treatment Therefore, incorporating preclinical models that mimic human cancer biology and drug responses is essential for improving treatment efficacy and prognosis Patient-derived xenograft (PDX) models, as a
- How vision and leadership shaped the U. S. National Cancer Institutes . . .
The requirement placed the NCI at the nexus of a rapidly changing science and a complex and dynamic healthcare delivery system and involved an evolutionary transformation to advance cancer control and cancer care delivery research along the cancer care continuum
- Clinical advances of mRNA vaccines for cancer immunotherapy
The development of mRNA vaccines represents a significant advancement in cancer treatment, with more than 120 clinical trials to date demonstrating their potential across various malignancies, including lung, breast, prostate, melanoma, and more challenging cancers such as pancreatic and brain tumors These vaccines work by encoding tumor-specific antigens and immune-stimulating molecules
- Global alliances in translational cancer research - ScienceDirect
Translating basic cancer biology into effective clinical therapies remains a major challenge due to differences in research models, communication gaps, and limited funding This commentary underscores the transformative potential of international collaborations, which integrate diverse resources, multidisciplinary talents, and innovative trial designs to bridge the gap between laboratory
- Developing a practice framework for patient navigation in cancer care . . .
To clarify the scope of patient navigation and support global implementation, the Global Initiative to Advance Cancer Navigation for Better Outcomes (GINO) aimed to develop a practice framework for patient navigation in cancer care Phase 1 involved reviewing patient navigation literature and identifying key areas of practice
- Big Data, Machine Learning, and Artificial Intelligence to Advance . . .
The rapid advances in artificial intelligence (AI), big data, and machine learning (ML) technologies hold promise for personalized, equitable cancer care and improved health outcomes within the context of cancer and beyond Furthermore, integrating these technologies into cancer research has been effective in addressing many of the challenges for cancer control and cure This can be achieved
- Timing of advance care planning in patients with advanced cancer . . .
In a qualitative study, patients with advanced cancer and family members reported ACP often occurred too late to put plans in place to ensure a patient’s preferences can be met [13] Research has consistently shown that determining the optimal timing for initiating ACP conversations is both critical and difficult [23], [24]
- Factors affecting advance care planning in older adults with cancer
Advance care planning (ACP) has been widely endorsed and recommended for its many potential benefits, including improved end-of-life (EOL) care, enhanced satisfaction with care, and reduced anxiety and depression However, little is known about the ACP completion rates and factors affecting ACP among older adults with cancer This study's purpose was to examine biological, psychological, and
|
|